Literature DB >> 20139541

Awareness and knowledge of mother-to-child transmission of HIV among mothers attending the pediatric HIV clinic, Kano, Nigeria.

S I Adeleke1, M Mukhtar-Yola, G D Gwarzo.   

Abstract

BACKGROUND: Nigeria accounts for about 10% of all HIV/AIDS cases in the world. Globally women constitute 48% of adults infected with HIV; in Nigeria, they constitute 57%. There is an increase in the number of children infected with HIV in recent years as the number of HIV-positive women has increased. However, more than 90% of HIV infections in children aged less than 15 years are due to mother-to-child transmission of HIV.
OBJECTIVE: To evaluate the awareness and knowledge of mother-to-child transmission of HIV, HIV/AIDS and the methods to prevent mother-to-child transmission of HIV.
METHODS: This is a descriptive study. The study was carried out at the pediatric HIV clinic of Aminu Kano Teaching Hospital from 1 st July 2006 to 30 th December 2006. Mothers included in the study were mothers in first contact with HIV facilities, which was at our center, before any form of counseling. The instrument used was a questionnaire designed to assess awareness of the mothers about HIV/AIDS, evaluate their knowledge of possible routes of transmission and measures to prevent vertical transmission. The questionnaire was then pre-tested for comprehensibility, appropriateness of language, sensitivity of questions and average duration of administration.
RESULTS: A total of 164 mothers brought their children for treatment to the pediatric HIV clinic. The level of awareness about HIV/AIDS among mothers was very high (100%), and the main sources of information were radio (48.8%) and television (37.8%). Ninety-one percent of mothers were aware of mother-to-child transmission of HIV. Transplacental route (41%) was the commonly identified route of transmission. The level of knowledge and perceptions of mother-to-child transmission of HIV is inadequate.
CONCLUSION: There is a need to scale up education about mother-to-child transmission of HIV in our health facilities.

Entities:  

Mesh:

Year:  2009        PMID: 20139541     DOI: 10.4103/1596-3519.59573

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  6 in total

1.  Virologic and immunologic outcome of treatment of HIV infection with a herbal concoction, α-Zam, among clients seeking herbal remedy in Nigeria.

Authors:  A A Onifadee; A P Jewel; A B Okesina
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-10-02

2.  Knowledge of HIV/AIDS and Attitude Toward Voluntary Counselling and Testing Among Antenatal Clinic Attendees at a Tertiary Care Hospital in India.

Authors:  H Sagili; S Kumar; S Lakshminarayanan; D Papa; C Abi
Journal:  J Obstet Gynaecol India       Date:  2014-10-31

3.  Barriers to uptake of prevention of mother-to-child transmission of HIV services among mothers of vertically infected HIV-seropositive infants in Makurdi, Nigeria.

Authors:  Emmanuel Ademola Anígilájé; Bem Ruben Ageda; Nnamdi Okechukwu Nweke
Journal:  Patient Prefer Adherence       Date:  2016-01-27       Impact factor: 2.711

4.  Perception on prevention of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age group in Osogbo, Southwestern Nigeria.

Authors:  Ai Olugbenga-Bello; Wo Adebimpe; Ff Osundina; St Abdulsalam
Journal:  Int J Womens Health       Date:  2013-07-11

Review 5.  Socio-cultural factors influencing the prevention of mother-to-child transmission of HIV in Nigeria: a synthesis of the literature.

Authors:  Juliet Iwelunmor; Echezona E Ezeanolue; Collins O Airhihenbuwa; Michael C Obiefune; Chinenye O Ezeanolue; Gbenga G Ogedegbe
Journal:  BMC Public Health       Date:  2014-07-30       Impact factor: 3.295

6.  Feasibility of home-based HIV counselling and testing and linking to HIV services among women delivering at home in Geita, Tanzania: a household longitudinal survey.

Authors:  Juma Adinan; Bridgit Adamou; Caroline Amour; Aisa Shayo; Paulo Lino Kidayi; Levina Msuya
Journal:  BMC Public Health       Date:  2019-12-30       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.